About this ingredient
AC-262,536, commonly referred to as AC-262 or Acadibol, is an experimental selective androgen receptor modulator (SARM). It was pharmacologically investigated because of its activity at the androgen receptor. A published preclinical study identified AC-262536 as a selective androgen-receptor ligand and evaluated its anabolic and androgenic effects in laboratory models.
Research on AC-262536 has primarily involved preclinical models rather than established human clinical use. The original pharmacological research reported anabolic effects in castrated male rats, including effects on levator ani muscle, while observing weaker effects on prostate and seminal-vesicle tissues than testosterone in that animal model. These findings should not be interpreted as proof of equivalent effects or safety in humans.
AC-262 is therefore different from ordinary ingredients such as vitamins, minerals, amino acids or herbal extracts. It should not be described on a Wellmart.pk consumer supplement page as an established muscle-building supplement or as a proven treatment.
The U.S. FDA lists AC-262536 under its information concerning dietary-supplement ingredients/substances and identifies it in connection with its SARM safety communication. FDA states that SARMs are not FDA-approved and that products containing SARMs are not legally marketed as dietary supplements in the United States.
FDA warnings concerning SARM-containing bodybuilding products include reports and potential risks involving liver injury, cardiovascular events, sexual dysfunction, infertility and other serious adverse effects. These warnings concern SARMs generally and should not be represented as evidence that every listed effect has been specifically established for AC-262 in humans.
AC-262536 is also relevant to anti-doping research. Scientific literature describes its detection and metabolism in animal studies, and WADA-related documentation identifies SARM AC-262,536 among prohibited anabolic agents.

